Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.278
-0.072 (-3.06%)
Oct 27, 2025, 4:29 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 743.87 million as of October 27, 2025. Its market cap has decreased by -55.38% in one year.
Market Cap
743.87M
Enterprise Value
67.20M
Revenue
79.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.28
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 743.87M, a decrease of -86.53%. That is a compound annual growth rate of -29.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 767.38M | -22.85% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.75B |
| Nordhealth AS | 2.83B |
| ArcticZymes Technologies ASA | 1.53B |
| Photocure ASA | 1.35B |
| Thor Medical ASA | 1.25B |
| Vistin Pharma ASA | 980.02M |
| Omda AS | 963.86M |
| Gentian Diagnostics ASA | 817.38M |